Thomas B. Davis

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes”.

APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes

Cancers(2021)10.3390/cancers13215394

N/A

0DataRank · unranked

23 citations

Mingli Yang, Lance Pflieger, Michael J. Schell, Malini Rajan, Thomas B. Davis +5 more

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

BMC Cancer(2022)10.1186/s12885-022-09344-3

N/A

0DataRank · unranked

22 citations

Thomas B. Davis, Lance Pflieger, Michael Nebozhyn, Andrey Loboda, Heiman Wang +5 more

Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer

Cancers(2022)10.3390/cancers14061451

N/A

0DataRank · unranked

4 citations

Shilpa Gupta, Mingli Yang, Lance Pflieger, Malini Rajan, Heiman Wang +4 more